Axxam SpA-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Axxam SpA - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011791
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イタリア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥26,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥53,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥80,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Axxam SpA (Axxam) is a partner research organization that provides drug discovery services. The organization offers drug discovery services such as molecular biology, assay development and reagent provision, compound management, hit characterization and profiling and electrophysiology, among others. It has developed proprietary technologies including photina, i-photina and champion technology to develop high throughput screening assays. Axxam offers a pipeline of drug discovery programs in the therapeutic areas of pain, metabolic disorders, Alzheimer’s disease, inflammation and autoimmune diseases. The organization serves pharmaceutical, animal health, crop protection, cosmetics and nutrition companies. It has chemistry laboratories located in Naples. Axxam is headquartered in Milan, Italy.

Axxam SpA – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Axxam SpA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Axxam SpA, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Axxam SpA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Axxam SpA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Axxam SpA, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Axxam SpA, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Axxam Acquires QPatch 16X From Sophion Bioscience 10
Venture Financing 11
Acousia Therapeutics Raises USD2.7 Million in Venture Financing 11
Partnerships 12
Axxam Enters into Research Agreement with Sanofi 12
Grunenthal Enters into Agreement with Axxam 13
Axxam Partners with Neomed Institute 14
Lead Discovery Center, Centre for Drug Design and Discovery and Axxam Form Joint Venture 15
Fast Forward And Juvenile Diabetes Research Foundation Extend Co-Development Agreement With Axxam 16
Axxam Enters Into Co-Development Agreement With Polyphor 17
Axxam Forms Joint Venture With InterMed Discovery 18
Axxam SpA – Key Competitors 19
Axxam SpA – Key Employees 20
Axxam SpA – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Joint Venture 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Axxam SpA, Pharmaceuticals & Healthcare, Key Facts 2
Axxam SpA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Axxam SpA, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Axxam SpA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Axxam SpA, Deals By Therapy Area, 2011 to YTD 2017 8
Axxam SpA, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Axxam Acquires QPatch 16X From Sophion Bioscience 10
Acousia Therapeutics Raises USD2.7 Million in Venture Financing 11
Axxam Enters into Research Agreement with Sanofi 12
Grunenthal Enters into Agreement with Axxam 13
Axxam Partners with Neomed Institute 14
Lead Discovery Center, Centre for Drug Design and Discovery and Axxam Form Joint Venture 15
Fast Forward And Juvenile Diabetes Research Foundation Extend Co-Development Agreement With Axxam 16
Axxam Enters Into Co-Development Agreement With Polyphor 17
Axxam Forms Joint Venture With InterMed Discovery 18
Axxam SpA, Key Competitors 19
Axxam SpA, Key Employees 20
Axxam SpA, Other Locations 21
Axxam SpA, Joint Venture 21

★海外企業調査レポート[Axxam SpA-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • PolyNovo Limited (PNV):企業の財務及び戦略的SWOT分析
    Summary PolyNovo Limited (PolyNovo), formerly Calzada Limited is a medical device company that designs, develops and manufactures solutions for standalone and combination devices. The company offers products such as biodegradable temporizing matrix and negative pressure wound therapy dressing system …
  • juwi AG:企業のM&A・提携動向(発電分野)
    Summary juwi AG (juwi) a subsidiary of MVV Energie AG, is a renewable energy company that offers project development and engineering procurement and construction services; and products and solutions for the energy turnaround. It offers whole-scale project development services for the planning and co …
  • Mayne Pharma Group Ltd (MYX):企業財務及び戦略的SWOT分析
    Summary Mayne Pharma Group Ltd (Mayne Pharma), formerly Mayne Pharma International Pty Ltd is a healthcare company that develops, manufactures, and commercializes branded and generic medicinal products. The company’s products include astrix capsules and tablets, erymax capsules, kapanol capsules, do …
  • Penumbra Inc (PEN):企業の財務・戦略的SWOT分析
    Penumbra Inc (PEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • China National Nuclear Power Co., Ltd. (601985):企業財務及び戦略的SWOT分析
    Summary China National Nuclear Power Co., Ltd. (CNNC), a subsidiary of China National Nuclear Corporation is an energy company that operates nuclear power projects. The company develops business of nuclear power projects, operation and management, construction, safety of nuclear power technology res …
  • Kukje Pharmaceutical Industry Co., Ltd. (002720):企業の財務及び戦略的SWOT分析
    Summary Kukje Pharmaceutical Industry Co., Ltd. (Kukje) is a pharmaceutical company that manufactures, sells and distributes pharmaceuticals, cosmetics and healthcare products. The company offers raw materials, intermediates and finished products. Its product line includes antibiotics such as penici …
  • Bionomics Limited (BNO)(製薬・医療分野):企業M&A動向
    Summary Bionomics Limited (Bionomics) is a biopharmaceutical company. The company discovers and develops drugs for treatment of cancer, and central nervous system disorders such as anxiety, depression and Alzheimer's disease. Its products include BNC 105, BNC210, K v 1.3 blockers, BN069, GABA-A Agon …
  • Halt Medical Inc:企業のM&A・提携動向(医療機器分野)
    Summary Halt Medical Inc (Halt Medical) is a healthcare company that designs, develops, manufactures, markets, and commercializes medical treatment and devices. The company offers Acessa system and procedure for the treatment of women suffering with symptomatic uterine fibroids. It offers services s …
  • EQDOM S.A.の企業概要及び財務/SWOT分析
    EQDOM S.A. Fundamental Company Report provides a complete overview of the company’s affairs. The report includes financial and SWOT information, industry analysis, opinions, estimates, EQDOM S.A. annual and quarterly forecasts made by stock market experts. The report also enables direct comparison t …
  • TSH Resources Bhd (TSH):企業概要、財務及び戦略的SWOT分析
    Summary TSH Resources Bhd (TSH) is a palm oil company. The company cultivates, processes and refines oil palm. Its business includes plantation, and synergistic integration, among others. TSH produces oil palm ramets with high fresh fruit bunches (FFB) yield and oil extraction rate (OER) for the pal …
  • Vasamed Inc.:企業の戦略的SWOT分析
    Vasamed Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Forma Therapeutics Inc:企業のM&A・事業提携・投資動向
    Forma Therapeutics Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Forma Therapeutics Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Calpine Corporation:戦略・SWOT・企業財務分析
    Calpine Corporation - Strategy, SWOT and Corporate Finance Report Summary Calpine Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Radius Health, Inc.:企業のM&A・提携・投資分析
    Radius Health, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Radius Health, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • iRobot Corporation (IRBT):企業の財務及び戦略的SWOT分析
    iRobot Corporation (IRBT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • The National Gas Company of Trinidad and Tobago Limited:企業のM&A・提携動向(石油・ガス分野)
    Summary The National Gas Company of Trinidad and Tobago Limited (NGC) is a diversified state-owned natural gas company. Its core business is the purchase, compression, transmission, distribution and sale of natural gas to industrial and commercial customers. The company also has investments in the d …
  • Esterline Technologies Corporation:企業のM&A・提携・投資分析
    Esterline Technologies Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Esterline Technologies Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on m …
  • Marion Energy Limited (MAE):企業概要、財務及び戦略的SWOT分析
    Summary Marion Energy Limited (Marion Energy) is an oil and gas exploration company. The company develops, produces, and sells oil and gas in Texas, Oklahoma, Utah, and the US. Its core operation is located primarily in the Uinta Basin of Central Utah. The company also holds additional acreage posit …
  • Lockheed Martin Aeronautics Company:企業の戦略・SWOT・財務情報
    Lockheed Martin Aeronautics Company - Strategy, SWOT and Corporate Finance Report Summary Lockheed Martin Aeronautics Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Medical & Biological Laboratories Co., Ltd. (4557):企業概要、財務及び戦略的SWOT分析
    Summary Medical & Biological Laboratories Co., Ltd. (MBL) is a pharmaceutical products manufacturer. The company develops and manufactures clinical diagnostics and basic laboratory diagnostics. It offers products such as research reagents, clinical diagnostic, gynecological examination area and cell …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆